boi568
3 minutes ago
I've always been, and remain, optimistic about the 2b/3 OLE results on safety and implied clinical effect. This is partly based on the tiny 2a extension, but also because the MOA seems multifactorial and clearly upstream. This contrasts with the Mabs, which do not address a root cause but a symptom,
BigBadWolf
3 minutes ago
Authorized Shares 15,925,000,000 11/20/2024
Outstanding Shares 5,451,760,661 11/20/2024 475m
Authorized Shares 15,925,000,000 11/1